Christopher M. Counter
1992–2022 年に発表
- 別表記
- Christopher M Counter
- 58
- 論文数
- 19,758
- 被引用数
- 53
- h 指数
- 58
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine48.6%
- Biochemistry, Genetics and Molecular Biology40.7%
- Immunology and Microbiology2.8%
- Nursing2.7%
- Materials Science1.6%
- Neuroscience0.8%
- その他2.8%
トピック
- Telomeres, Telomerase, and Senescence9.3%
- Mitochondrial Function and Pathology2.7%
- DNA Repair Mechanisms2.2%
- Cancer-related Molecular Pathways2.2%
- RNA Interference and Gene Delivery2%
- Advanced biosensing and bioanalysis techniques1.9%
- その他79.7%
共著者
- Kian‐Huat Lim8
- Silvia Bacchetti7
- Channing J. Der6
- Robert A. Weinberg6
- Soma S. R. Banik6
- Calvin B. Harley5
- David F. Kashatus5
- Donita C. Brady5
- Adrienne D. Cox4
- Corinne M. Linardic4
- Matthew Meyerson4
- Nicole L. Pershing4
- Siqi Li4
- Xiao‐Fan Wang4
- Benjamin L. Lampson3
- Blaine N. Armbruster3
- Brooke B. Ancrile3
- Daniel A. Haber3
- David M. MacAlpine3
- Elinor Ng Eaton3
- Erin Kaltenbrun3
- Jeremy N. Rich3
- Katherine T. Etheridge3
- Leif W. Ellisen3
全論文
- Erk2 Phosphorylation of Drp1 Promotes Mitochondrial Fission and MAPK-Driven Tumor Growth
著者: Jennifer A. Kashatus, Aldo Nascimento, Lindsey J. Myers, Annie Sher, Frances L. Byrne, Kyle L. Hoehn, Christopher M. Counter, David F. Kashatus - Molecular Cell 2015 被引用: 705
- Copper is required for oncogenic BRAF signalling and tumorigenesis
著者: Donita C. Brady, Matthew S. Crowe, Michelle L. Turski, G. Aaron Hobbs, Xiaojie Yao, A. Chaikuad, Stefan Knapp, Kunhong Xiao, Sharon L. Campbell, Dennis J. Thiele, Christopher M. Counter - Nature 2014 被引用: 612
- A model for RAS mutation patterns in cancers: finding the sweet spot
著者: Siqi Li, Allan Balmain, Christopher M. Counter - Nature reviews. Cancer 2018 被引用: 392
- A Novel Role for Copper in Ras/Mitogen-Activated Protein Kinase Signaling
著者: Michelle L. Turski, Donita C. Brady, Hyung J. Kim, Byung-Eun Kim, Yasuhiro Nose, Christopher M. Counter, Dennis R. Winge, Dennis J. Thiele - Molecular and Cellular Biology 2012 被引用: 317
- Copper Chelation Inhibits BRAFV600E-Driven Melanomagenesis and Counters Resistance to BRAFV600E and MEK1/2 Inhibitors
著者: Donita C. Brady, Matthew S. Crowe, Danielle Greenberg, Christopher M. Counter - Cancer Research 2017 被引用: 166
- Creation of human tumour cells with defined genetic elements
著者: William C. Hahn, Christopher M. Counter, Ante S. Lundberg, Roderick L. Beijersbergen, Mary W. Brooks, Robert A. Weinberg - Nature 1999 被引用: 2,352
- A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells
著者: Elizabeth S. Yeh, Melissa Cunningham, Hugh Arnold, Dawn A. D. Chasse, Teresa Monteith, Gilles Ivaldi, William C. Hahn, P. Todd Stukenberg, Shirish Shenolikar, Takafumi Uchida, Christopher M. Counter, Joseph R. Nevins, Anthony R. Means, Rosalie C. Sears - Nature Cell Biology 2004 被引用: 791
- RALA and RALBP1 regulate mitochondrial fission at mitosis
著者: David F. Kashatus, Kian‐Huat Lim, Donita C. Brady, Nicole L. Pershing, Adrienne D. Cox, Christopher M. Counter - Nature Cell Biology 2011 被引用: 391
- Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.
著者: Christopher M. Counter, Ariel A. Avilion, Catherine LeFeuvre, Nancy Stewart, Carol W. Greider, Calvin B. Harley, Silvia Bacchetti - The EMBO Journal 1992 被引用: 2,109
- CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment
著者: Jennifer E. Klomp, Ye S. Lee, Craig M. Goodwin, Björn Papke, Jeffrey A. Klomp, Andrew M. Waters, Clint A. Stalnecker, Jonathan M. DeLiberty, Kristina Drizyte‐Miller, Runying Yang, J. Nathaniel Diehl, Hongwei Yin, Mariaelena Pierobon, Elisa Baldelli, Meagan B. Ryan, Siqi Li, Jackson J. Peterson, Amber R. Smith, James T. Neal, Aaron K. McCormick, Calvin J. Kuo, Christopher M. Counter, Emanuel F. Petricoin, Adrienne D. Cox, Kirsten L. Bryant, Channing J. Der - Cell Reports 2021 被引用: 42
- Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis
著者: Brooke Ancrile, Kian‐Huat Lim, Christopher M. Counter - Genes & Development 2007 被引用: 418
- hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization
著者: Matthew Meyerson, Christopher M. Counter, Elinor Ng Eaton, Leif W. Ellisen, Philipp Steiner, Stephanie Dickinson Caddle, Liuda Ziaugra, Roderick L. Beijersbergen, Michael J. Davidoff, Qingyun Liu, Silvia Bacchetti, Daniel A. Haber, Robert A. Weinberg - Cell 1997 被引用: 1,801
- A Genetic Porcine Model of Cancer
著者: Lawrence B. Schook, Tiago Collares, Wenping Hu, Ying Liang, Fernanda Martins Rodrigues, Laurie A. Rund, Kyle M. Schachtschneider, Fabiana K. Seixas, Kuldeep Singh, Kevin D. Wells, Eric M. Walters, Randall S. Prather, Christopher M. Counter - PLoS ONE 2015 被引用: 159
- Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability
著者: Hema Adhikari, Christopher M. Counter - Nature Communications 2018 被引用: 92
- Tumour maintenance is mediated by eNOS
著者: Kian‐Huat Lim, Brooke B. Ancrile, David F. Kashatus, Christopher M. Counter - Nature 2008 被引用: 321
- The telomere hypothesis of cellular aging
著者: Calvin B. Harley, Homayoun Vaziri, Christopher M. Counter, Richard Allsopp - Experimental Gerontology 1992 被引用: 493
- Bone formation by human postnatal bone marrow stromal stem cells is enhanced by telomerase expression
著者: Songtao Shi, Stan Gronthos, Shaoqiong Chen, A. Hari Reddi, Christopher M. Counter, Pamela Gehron Robey, Cun-Yu Wang - Nature Biotechnology 2002 被引用: 378
- Activation of RalA is critical for Ras-induced tumorigenesis of human cells
著者: Kian‐Huat Lim, Antonio T. Baines, James J. Fiordalisi, Michail Shipitsin, Larry A. Feig, Adrienne D. Cox, Channing J. Der, Christopher M. Counter - Cancer Cell 2005 被引用: 361
- The Cytoplasmic Deacetylase HDAC6 Is Required for Efficient Oncogenic Tumorigenesis
著者: Yi-Shan Lee, Kian‐Huat Lim, Xingrong Guo, Yoshiharu Kawaguchi, Ya‐sheng Gao, Tomasa Barrientos, Peter Ordentlich, Xiao‐Fan Wang, Christopher M. Counter, Tso‐Pang Yao - Cancer Research 2008 被引用: 260
- A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution
著者: Grace R. Anderson, Peter Winter, Kevin Lin, Daniel P. Nussbaum, Merve Çakır, Elizabeth M. Stein, Ryan S. Soderquist, Lorin Crawford, Jim C. Leeds, Rachel Newcomb, Priya Stepp, Catherine Yip, Suzanne E. Wardell, Jennifer P. Tingley, Moiez Ali, Mengmeng Xu, Meagan B. Ryan, Shannon J. McCall, Autumn J. McRee, Christopher M. Counter, Channing J. Der, Kris C. Wood - Cell Reports 2017 被引用: 86
- Oncogenic KRAS is dependent upon an EFR3A-PI4KA signaling axis for potent tumorigenic activity
著者: Hema Adhikari, Walaa E. Kattan, S. Kumar, Pei Zhou, John F. Hancock, Christopher M. Counter - Nature Communications 2021 被引用: 53
- Distinct responses to rare codons in select Drosophila tissues
著者: Scott R Allen, Rebeccah K Stewart, Michael Rogers, Ivan Jimenez Ruiz, Erez Cohen, Alain Laederach, Christopher M Counter, Jessica K Sawyer, Donald T Fox - eLife 2022 被引用: 30
- Rare Codons Regulate KRas Oncogenesis
著者: Benjamin L. Lampson, Nicole L. Pershing, Joseph A. Prinz, Joshua R. Lacsina, William F. Marzluff, Christopher V. Nicchitta, David M. MacAlpine, Christopher M. Counter - Current Biology 2012 被引用: 151
- Defining the Cooperative Genetic Changes That Temporally Drive Alveolar Rhabdomyosarcoma
著者: Sarasija Naini, Katherine T. Etheridge, Stacey J. Adam, Stephen J. Qualman, Rex C. Bentley, Christopher M. Counter, Corinne M. Linardic - Cancer Research 2008 被引用: 84
